CBD Dosing Mitigates Spondyloarthritis Pain In Brazilian Case Report
Spondyloarthritis, sometimes referred to as spondyloarthropathy, is an inflammatory arthritis condition that affects the patient’s spine. The main symptom of spondyloarthritis in most suffering patients involves low back pain.
According to a study from 2020, researchers estimated that as many as .5% to 2% of the world’s population suffers from spondyloarthritis to some degree. Common treatments for the condition depend on the severity of spondyloarthritis in the patient.
Researchers in Brazil recently published findings for a case report involving cannabidiol (CBD) and spondyloarthritis. Below is more information about the study and its results via a news release from NORML:
São José do Rio Preto, Brazil: The daily administration of plant-derived CBD oil is associated with reduced spondyloarthritis-related pain and increased physical activity, according to a case report published in the journal Cureus.
A Brazilian researcher documented improvements in a 72-year-old male patient with neuropathic pain from spondyloarthritis, a chronic inflammatory disease that predominantly affects the spinal column. The patient suffered from chronic pain, numbness, diminished muscle strength, and limited movement due to his condition.
Treatment with CBD oil resulted in initial improvements within 20 days. These improvements became more pronounced over time. “After 90 days of treatment, the patient reported the absence of pain, the return of physical activity (walking and swimming), and the suspension of the use of analgesics. Muscle strength increased considerably and tremors in the left arm had diminished by 90 percent.”
The study’s author concluded, “Based on this result and considering scientific evidence of the effectiveness of CBD in the treatment of patients with chronic pain due to different illnesses, this therapeutic option may be beneficial to such patients when conventional medicinal treatment is unsatisfactory.”
Full text of the study, “Cannabidiol for the treatment of spondyloarthritis-related pain: A case report,” appears in Cureus. Additional information on cannabinoids and pain management is available from NORML’s publication, Clinical Applications for Cannabis and Cannabinoids.
